ArticleFrontiers in oncology2022

Development and Validation of a Four Adenosine-to-Inosine RNA Editing Site-Relevant Prognostic Signature for Assessing Survival in Breast Cancer Patients.

Jian Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.